InflaRx NV Financials
| IFRX Stock | USD 2.37 0.13 5.20% |
InflaRx |
Understanding current and past InflaRx NV Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of InflaRx NV's financial statements are interrelated, with each one affecting the others. For example, an increase in InflaRx NV's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in InflaRx NV's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of InflaRx NV. Check InflaRx NV's Beneish M Score to see the likelihood of InflaRx NV's management manipulating its earnings.
InflaRx NV Stock Summary
InflaRx NV competes with Generation Bio, Kronos Bio, Erasca, C4 Therapeutics, and Edgewise Therapeutics. InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. InflaRx N.V. was founded in 2007 and is headquartered in Jena, Germany. Fireman BV is traded on NASDAQ Exchange in the United States.Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | NL0012661870 |
| CUSIP | N44821101 |
| Location | Germany |
| Business Address | Winzerlaer Str 2, |
| Sector | Biotechnology |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.inflarx.de |
| Phone | 49 3641 508 180 |
| Currency | USD - US Dollar |
InflaRx NV Key Financial Ratios
InflaRx Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining InflaRx NV's current stock value. Our valuation model uses many indicators to compare InflaRx NV value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across InflaRx NV competition to find correlations between indicators driving InflaRx NV's intrinsic value. More Info.InflaRx NV is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the InflaRx NV's earnings, one of the primary drivers of an investment's value.InflaRx NV Systematic Risk
InflaRx NV's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. InflaRx NV volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on InflaRx NV correlated with the market. If Beta is less than 0 InflaRx NV generally moves in the opposite direction as compared to the market. If InflaRx NV Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one InflaRx NV is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of InflaRx NV is generally in the same direction as the market. If Beta > 1 InflaRx NV moves generally in the same direction as, but more than the movement of the benchmark.
Steps to analyze company Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as InflaRx NV is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of InflaRx has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if InflaRx NV's financials are consistent with your investment objective using the following steps:- Review InflaRx NV's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand InflaRx NV's liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare InflaRx NV's financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if InflaRx NV's stock is overvalued or undervalued.
InflaRx NV January 23, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of InflaRx NV help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of InflaRx NV. We use our internally-developed statistical techniques to arrive at the intrinsic value of InflaRx NV based on widely used predictive technical indicators. In general, we focus on analyzing InflaRx Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build InflaRx NV's daily price indicators and compare them against related drivers.
| Downside Deviation | 4.5 | |||
| Information Ratio | 0.1461 | |||
| Maximum Drawdown | 29.48 | |||
| Value At Risk | (6.44) | |||
| Potential Upside | 11.35 |
Additional Tools for InflaRx Stock Analysis
When running InflaRx NV's price analysis, check to measure InflaRx NV's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy InflaRx NV is operating at the current time. Most of InflaRx NV's value examination focuses on studying past and present price action to predict the probability of InflaRx NV's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move InflaRx NV's price. Additionally, you may evaluate how the addition of InflaRx NV to your portfolios can decrease your overall portfolio volatility.